President and CEO
AC
Aphios Corporation
The startup develops cannabis-based pharmaceuticals targeting peripheral nervous system disorders, including Alzheimer's disease and certain cancers. Their formulations utilize cannabinoids to modulate neuroinflammation and promote neuroprotection, providing new treatment options for patients with these conditions.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$300KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops cannabis-based pharmaceuticals targeting peripheral nervous system disorders, including Alzheimer's disease and certain cancers. Their formulations utilize cannabinoids to modulate neuroinflammation and promote neuroprotection, providing new treatment options for patients with these conditions.